Bioequivalence and Food Effect Assessment of 2 Fixed‐Dose Combination Formulations of Dolutegravir and Lamivudine

This single‐dose study evaluated the bioequivalence, food effect, and safety of 2 experimental, 2‐drug, fixed‐dose formulations of 50 mg dolutegravir and 300 mg lamivudine (formulation AH and formulation AK) as compared with coadministration of single‐entity tablets of 50 mg dolutegravir and 300 mg...

Descripción completa

Detalles Bibliográficos
Autores principales: Dumitrescu, Teodora Pene, Peddiraju, Kavita, Fu, Caifeng, Bakshi, Kalpana, Yu, Shui, Zhang, Zhiping, Tenorio, Allan R., Spancake, Chris, Joshi, Shashidhar, Wolstenholme, Allen, Adkison, Kimberly
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028125/
https://www.ncbi.nlm.nih.gov/pubmed/31724343
http://dx.doi.org/10.1002/cpdd.740

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7028125/
https://www.ncbi.nlm.nih.gov/pubmed/31724343
http://dx.doi.org/10.1002/cpdd.740

Ejemplares similares